Why is Monte Rosa Therapeutics stock plunging today?

Market volatility has severely impacted several biotechnology firms today. Monte Rosa Therapeutics is experiencing a significant stock plunge. Simultaneously, BioAge Labs has seen its stock value plummet by 60%. Karyopharm Therapeutics is facing a similar collapse, with its stock price also dropping over 60%. These three companies are all witnessing sharp declines in their market valuations, reflecting a broader trend of instability within the specific sector as investors react to current financial developments.